OLARATUMAB for Angiosarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 7 adverse event reports in the FDA FAERS database where OLARATUMAB was used for Angiosarcoma.

Most Reported Side Effects for OLARATUMAB

Side Effect	Reports	%	Deaths	Hosp.
Off label use	124	22.0%	32	29
Neutropenia	66	11.7%	2	11
Infusion related reaction	64	11.3%	2	25
Febrile neutropenia	57	10.1%	6	36
Drug ineffective	49	8.7%	10	12
Death	44	7.8%	44	3
Malignant neoplasm progression	43	7.6%	10	8
Product use in unapproved indication	40	7.1%	7	14
Disease progression	33	5.8%	10	5
Anaphylactic reaction	29	5.1%	0	13
Dyspnoea	27	4.8%	4	12
Diarrhoea	21	3.7%	2	11
Fatigue	20	3.5%	1	2
Nausea	19	3.4%	1	5
Neoplasm recurrence	19	3.4%	1	0